XML 21 R6.htm IDEA: XBRL DOCUMENT v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Common Stock
Class A Ordinary Shares
Common Stock
Class B Ordinary Shares
Preferred shares
Additional paid-in capital
Subscription receivable
Statutory reserve
Accumulated deficit
Accumulated Other Comprehensive (loss) income
Total shareholders' equity
Non-controlling interest
Class A Ordinary Shares
Total
Balance at beginning at Dec. 31, 2022 $ 11   $ 3 $ 312,831   $ 8 $ (283,008) $ 1,470 $ 31,315 $ 4,188   $ 35,503
Balance at beginning (in shares) at Dec. 31, 2022 8,453   56,000                  
STATEMENTS OF CHANGES IN EQUITY                        
Net loss             (53,563)   (53,563) 9   (53,554)
Vesting of restricted shares award $ 2     11,966         11,968     11,968
Vesting of restricted shares award (in shares) 1,543                      
Issuance of ordinary shares and warrant for private placement $ 8     18,892 $ (17,900)       1,000     1,000
Issuance of ordinary shares and warrant for private placement (in shares) 5,833                      
Issuance of ordinary shares for conversion of Series F convertible preferred shares $ 5   $ (1) 310         314     314
Issuance of ordinary shares for conversion of Series F convertible preferred shares (shares) 3,889   (7,000)                  
Issuance of ordinary shares for conversion of convertible preferred shares $ 5     60         65     65
Issuance of ordinary shares for conversion of convertible preferred shares (in shares) 3,631                      
Issuance of ordinary shares for payments of dividends (shares) 4                      
Foreign currency translation adjustment               (580) (580) (763)   (1,343)
Share based consideration on acquisition of a subsidiary $ 5     49,095         49,100     49,100
Share based consideration on acquisition of a subsidiary (shares) 3,704                      
Issuance of shares to settle payables for sales incentive       3,914         3,914     3,914
Issuance of shares to settle payables for sales incentive (shares) 368                      
Issuance of ordinary shares for conversion of convertible notes $ 1     2,049         2,050     2,050
Issuance of ordinary shares for conversion of convertible notes (shares) 245                   245  
Balance at ending at Dec. 31, 2023 $ 37   $ 2 399,117 (17,900) 8 (336,571) 890 45,583 3,434   49,017
Balance at ending (in shares) at Dec. 31, 2023 27,670   49,000                  
STATEMENTS OF CHANGES IN EQUITY                        
Net loss             (40,972)   (40,972) (8)   (40,980)
Vesting of restricted shares award $ 106 $ 50   10,700         10,856     10,856
Vesting of restricted shares award (in shares) 78,502 36,667                    
Issuance of ordinary shares and warrant for private placement $ 56     3,669         3,725     3,725
Issuance of ordinary shares and warrant for private placement (in shares) 41,365                      
Issuance of ordinary shares for conversion of convertible preferred shares $ 23               23     23
Issuance of ordinary shares for conversion of convertible preferred shares (in shares) 16,667   (500)                  
Issuance of Series G convertible preferred shares to settle payables due to purchaser of KAG     $ 1 1,995         1,996     1,996
Issuance of Series G convertible preferred shares to settle payables due to purchaser of KAG (Shares)     12,800                  
Issuance of Series H convertible preferred shares to settle payables for sales incentive     $ 1 987         988     988
Issuance of Series H convertible preferred shares to settle payables for sales incentive (Shares) 55   7,366                  
Issuance of ordinary shares for payments of dividends (shares) 56                      
Disposal of subsidiaries       (12,187)         (12,187) (3,324)   (15,511)
Foreign currency translation adjustment               1,073 1,073 (101)   972
Issuance of ordinary shares for conversion of convertible notes $ 25     2,063         2,088     2,088
Issuance of ordinary shares for conversion of convertible notes (shares) 18,657                   18,657  
Balance at ending at Dec. 31, 2024 $ 247 $ 50 $ 4 406,344 (17,900) 8 (377,543) 1,963 13,173 1   13,174
Balance at ending (in shares) at Dec. 31, 2024 182,972 36,667 68,666                  
STATEMENTS OF CHANGES IN EQUITY                        
Net loss             (53,907)   (53,907) (1)   (53,908)
Vesting of restricted shares award $ 620 $ 2,880   21,905         25,405     25,405
Vesting of restricted shares award (in shares) 458,849 2,133,334                    
Issuance of ordinary shares to the buyer of Morning Star (Note 3)     $ 1 7,799         7,800     7,800
Issuance of ordinary shares to the buyer of Morning Star (Note 3) (in shares)     10,000                  
Issuance of ordinary shares for conversion of convertible preferred shares $ 7,587   $ (2) (7,585)                
Issuance of ordinary shares for conversion of convertible preferred shares (in shares) 5,620,000   (12,000)                  
Disposal of subsidiaries                   (1)   (1)
Foreign currency translation adjustment               7 7 $ 1   8
Share based consideration on acquisition of a subsidiary $ 20,250     8,562         28,812     28,812
Share based consideration on acquisition of a subsidiary (shares) 15,000,000                      
Issuance of ordinary shares for conversion of convertible notes $ 24     614         638     638
Issuance of ordinary shares for conversion of convertible notes (shares) 17,971                   17,970  
Balance at ending at Dec. 31, 2025 $ 28,728 $ 2,930 $ 3 $ 437,639 $ (17,900) $ 8 $ (431,450) $ 1,970 $ 21,928     $ 21,928
Balance at ending (in shares) at Dec. 31, 2025 21,279,792 2,170,001 66,666